Xiao-Quan Xu Selected Research

Troleandomycin (TAO)

10/2022	Reduced cortical complexity in patients with thyroid-associated ophthalmopathy.
6/2022	Multiparametric magnetic resonance imaging for differentiating active from inactive thyroid-associated ophthalmopathy: Added value from magnetization transfer imaging.
1/2022	T2 -Weighted MR Imaging-Derived Radiomics for Pretreatment Determination of Therapeutic Response to Glucocorticoid in Patients With Thyroid-Associated Ophthalmopathy: Comparison With Semiquantitative Evaluation.
1/2022	Altered Long- and Short-Range Functional Connectivity Density in Patients With Thyroid-Associated Ophthalmopathy: A Resting-State fMRI Study.
7/2021	Usefulness of readout-segmented EPI-based diffusion tensor imaging of lacrimal gland for detection and disease staging in thyroid-associated ophthalmopathy.
6/2021	Texture analysis of orbital magnetic resonance imaging for monitoring and predicting treatment response to glucocorticoids in patients with thyroid-associated ophthalmopathy.
3/2021	Thyroid-Associated Ophthalmopathy: Preliminary Study Using T2 Mapping to Characterize Intraorbital Optic Nerve Changes Before Dysthyroid Optic Neuropathy.
2/2021	Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance.
1/2021	Disrupted Spontaneous Neural Activity in Patients With Thyroid-Associated Ophthalmopathy: A Resting-State fMRI Study Using Amplitude of Low-Frequency Fluctuation.
1/2021	Aberrant brain voxel-wise resting state fMRI in patients with thyroid-associated ophthalmopathy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Quan Xu Research Topics

Disease

15	Graves Ophthalmopathy 10/2022 - 01/2020
13	Ischemic Stroke 12/2022 - 09/2017
11	Stroke (Strokes) 12/2022 - 01/2013
4	Infarction (Infarctions) 12/2022 - 01/2013
3	Neoplasms (Cancer) 05/2022 - 08/2018
3	Thrombosis (Thrombus) 09/2018 - 01/2013
2	Papillary Thyroid Cancer 01/2022 - 11/2020
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021 - 09/2018
2	Ischemia 09/2018 - 09/2016
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 05/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2022
1	Lymphatic Metastasis 01/2022
1	Fibrosis (Cirrhosis) 12/2021
1	Exophthalmos (Proptosis) 03/2021
1	Optic Nerve Diseases (Optic Neuropathy) 03/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Cognitive Dysfunction 01/2021
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Brain Infarction 09/2018
1	Inflammation (Inflammations) 09/2018
1	Infections 06/2018
1	Nervous System Diseases (Neurological Disorders) 06/2018
1	Thyroid Neoplasms (Thyroid Cancer) 02/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2018
1	Adenocarcinoma of Lung 01/2017
1	Sensorineural Hearing Loss 01/2015
1	Carotid-Cavernous Sinus Fistula 04/2013
1	Fistula 04/2013

Drug/Important Bio-Agent (IBA)

15	Troleandomycin (TAO)FDA Link 10/2022 - 01/2020
5	Cytidine Triphosphate (CTP)IBA 08/2022 - 09/2019
3	IodineIBA 05/2022 - 11/2020
3	GlucocorticoidsIBA 01/2022 - 11/2020
3	Biomarkers (Surrogate Marker)IBA 08/2018 - 09/2017
2	CytokinesIBA 01/2019 - 06/2018
2	CD40 Ligand (CD40L)IBA 09/2018 - 09/2017
2	ferric oxide (iron oxide)IBA 06/2018 - 01/2013
1	fibrin fragment D (D-dimer)IBA 05/2022
1	Hematoxylin (Haematoxylon)IBA 12/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2021
1	Contrast MediaIBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	GadoliniumIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Troponin T (Troponin T1)IBA 06/2019
1	Conditioned Culture MediaIBA 01/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2018
1	PhycoerythrinIBA 09/2018
1	Sirolimus (Rapamycin)FDA Link 09/2018
1	Fluorescein-5-isothiocyanate (FITC)IBA 09/2018
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 09/2018
1	isothiocyanic acidIBA 09/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2018
1	Nerve Growth Factors (Neurotrophins)IBA 06/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2016
1	ferric ferrocyanide (Prussian blue)FDA Link 01/2013

Therapy/Procedure

6	Thrombectomy 12/2022 - 06/2019
6	Therapeutics 06/2021 - 09/2016
2	Catheters 07/2013 - 01/2013
1	Anesthesia 01/2019
1	Cochlear Implantation 01/2015
1	Retreatment 04/2013
1	Stents 04/2013
1	Cell Transplantation 01/2013
1	Transplantation 01/2013